drugset / Trial / NCT05277207

Tobacco Cessation Treatment Preferences Among Veteran Smokers

NCT05277207

Phase 4 Completed 30 enrolled VA Office of Research and Development
RandomizedParallel-groupOpen-labelTreatment

Summary

There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings. Specialty providers cite several barriers to delivering evidence-based tobacco cessation care, including insufficient time and lack of training. In addition, a large proportion of patients who begin tobacco cessation treatment do not quit. Use of healthcare technology (i.e., telehealth, electronic health record, and computerized treatment algorithms based on patient data) to improve patients' ability to quit tobacco use. The purpose of this study is to demonstrate the feasibility of a larger trial, and to evaluate the acceptability of the intervention design. Thirty participants will be assigned to receive either 1) a treatment that includes personalized counseling, tobacco cessation medications, and text messaging; or 2) referral to Department of Veterans Affairs' Quitline program plus SmokefreeVET, a text messaging program.

Timeline

Start
2022-05-02
Primary completion
2023-09-27
Completion
2023-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Varenicline Small molecule

Indications